parkinsons_contrast: Dopamine agonists as adjunct therapy in Parkinson's disease

In bnma: Bayesian Network Meta-Analysis using 'JAGS'

Dopamine agonists as adjunct therapy in Parkinson's disease

Description

A contrast level (i.e. treatment difference) dataset of 7 studies investigating the mean lost work-time reduction in patients given 4 dopamine agonists and placebo as adjunct therapy for Parkinson's disease. Placebo is coded as 1, and four active drugs are coded 2 to 5. There is placebo, coded as 1, and four active drugs coded 2 to 5.

Usage

parkinsons_contrast

Format

A list of Outcomes, Treat, SE, na, and V

References

S. Dias, A.J. Sutton, A.E. Ades, and N.J. Welton (2013a), A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials, Medical Decision Making 33(5):607-617. \Sexpr[results=rd]{tools:::Rd_expr_doi("10.1177/0272989X12458724")}

bnma documentation built on Aug. 15, 2023, 5:08 p.m.